Z. Karaca Et Al. , "VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma," EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.164, no.2, pp.277-284, 2011
Karaca, Z. Et Al. 2011. VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma. EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.164, no.2 , 277-284.
Karaca, Z., TANRIVERDİ, F., ÜNLÜHİZARCI, K., ÖZTÜRK, F., GÖKAHMETOĞLU, S., Elbuken, G., ... Cakir, I.(2011). VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma. EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.164, no.2, 277-284.
Karaca, Zahide Et Al. "VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma," EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.164, no.2, 277-284, 2011
Karaca, Zahide Et Al. "VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma." EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.164, no.2, pp.277-284, 2011
Karaca, Z. Et Al. (2011) . "VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma." EUROPEAN JOURNAL OF ENDOCRINOLOGY , vol.164, no.2, pp.277-284.
@article{article, author={Zahide KARACA Et Al. }, title={VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma}, journal={EUROPEAN JOURNAL OF ENDOCRINOLOGY}, year=2011, pages={277-284} }